Beta-cell function in type 2 diabetic patients who failed to maintain good glycemic status with a combination of maximum dosages of metformin and sulfonylurea
Tada Kunavisarut, Sutin Sriussadaporn, Raweewan LertwattanarakDivision of Endocrinology and Metabolism, Siriraj Hospital, Mahidol University, Bangkok, ThailandBackground: The aim of this study was to investigate beta-cell function and examine whether sulfonylureas (SUs) are still useful in patients...
Guardado en:
Autores principales: | Kunavisarut T, Sriussadaporn S, Lertwattanarak R |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ec77a9e9541b45dfb6109e2a52ad1ed9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effects of vildagliptin relative to sulfonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: influence of age and treatment with/without metformin in the VIRTUE study
por: Hassoun AAK, et al.
Publicado: (2016) -
Metformin-Insulin versus Metformin-Sulfonylurea Combination Therapies in Type 2 Diabetes: A Comparative Study of Glycemic Control and Risk of Cardiovascular Diseases in Addis Ababa, Ethiopia
por: Gebrie D, et al.
Publicado: (2021) -
Integrated effects of herbicides and foliar fertilizer on corn inbred line
por: Brankov,Milan, et al.
Publicado: (2020) -
Sulfonylureas and cardiovascular complications of type 2 diabetes mellitus
por: Lyudmila Viktorovna Nedosugova
Publicado: (2013) -
Pharmacoeconomic aspects of the use of sulfonylurea drugs in type 2 diabetes mellitus
por: Alla Vsevolodovna Rudakova
Publicado: (2011)